Clinical Trial Update: Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update for avapritinib in KIT or PDGFRA mutation-positive locally advanced or metastatic malignant solid tumors, currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Drugs mentioned

• Avapritinib (avapritinib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 | Phase 2 | Status: RECRUITING